Cholera Outbreak Strikes 29 Countries, Highlights Vaccine Shortage

The international group coordinating emergency vaccines recommends administering one dose instead of two to combat the “dire shortage” of cholera vaccines worldwide.

Written byKatherine Irving
| 3 min read
a person in a black shirt crouches on a dirt bank and cups water drawn from a river.
Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Widespread cholera outbreaks have forced health agencies to ration vaccines, raising questions about affected countries’ public health infrastructure. The disease has already infected hundreds of thousands of people this year, The New York Times reports. As a result, the International Coordinating Group (ICG), which manages the distribution of emergency vaccines and is made up of members of the World Health Organization (WHO) and humanitarian groups such as Doctors Without Borders and UNICEF, has recommended giving out just one vaccine dose per person instead of the full two-dose regimen, the WHO announced in a press release earlier this month (October 19).

Cholera is a bacterial infection typically spread through the ingestion of contaminated food or water. According to the Centers for Disease Control and Prevention (CDC), the main symptoms are profuse diarrhea and vomiting, resulting in severe dehydration. That dehydration leads to kidney failure, shock, and death in 3 percent of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • A black and white headshot of Katherine Irving

    Katherine Irving is an intern at The Scientist. She studied creative writing, biology, and geology at Macalester College, where she honed her skills in journalism and podcast production and conducted research on dinosaur bones in Montana. Her work has previously been featured in Science.  

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies